Cerebrospinal fluid TAU protein and amyloid β42 in mild cognitive impairment: prediction of progression to Alzheimer’s disease and correlation with the neuropsychological examination

References

• Adam , S , Van der Linden , M , Ivanoiu , A , Jullerat , A-C , Bechet , S and Salmon , E. in press . Optimization of encoding specificity for the diagnosis of early AD: The RI-48 task . J. Clin Exp Neuropsychol. ,
   Google Scholar
• Andreasen , N , Vanmechelen , E , Vanderstichele , H , Davidsson , P and Blennow , K. 2003 . Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer’s disease in patients with mild cognitive impairment . Acta Neurol Scand Suppl , 179 : 47 – 51 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMedGoogle Scholar
• Arai , H , Nakagawa , T Kosaka , Y . 1997 . Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired patients . Alzheimer’s Res , 3 : 211 – 13 . [CSA]
   Google Scholar
• Blennow , K and Hampel , H. 2003 . CSF markers for incipient Alzheimer’s disease . Lancet Neurol , 10 : 605 – 13 . [CROSSREF]
   Google Scholar
• Blennow , K and Vanmechelen , E. 2003 . CSF markers for pathogenic processes in Alzheimer’s disease: Diagnostic implications and use in clinical neurochemistry . Brain Res Bull , 61 : 235 – 42 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Braak , H and Braak , E. 1991 . Neuropathological stageing of Alzheimer-related changes . Acta Neuropathol (Berl) , 82 : 239 – 59 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buschke , H. 1984 . Cued recall in amnesia . Journal of Clinical Neuropsychology , 6 : 433 – 440 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Clark , CM , Xie , S , Chittams , J , Ewbank , D , Peskind , E Galasko , D . 2003 . Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? . Arch Neurol , 60 : 1696 – 702 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• de Leon , MJ , Segal , S , Tarshish , CY , DeSanti , S , Zinkowski , R Mehta , PD . 2002 . Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment . Neurosci Lett , 333 : 183 – 6 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• de Partz , MP , Bilocq , V , De Wilde , V , Seron , X and Pillon , A. 2001 . LEXIS : Tests pour l’évaluation des troubles lexicaux chez la personne aphasique , Marseille : Solal .
   Google Scholar
• DeCarli , C. 2003 . Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment . Lancet Neurol , 2 : 15 – 21 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Duyckaerts , C , Colle , MA , Delatour , B and Hauw , JJ. 2002 . “ Neuropathologie de la maladie d’Alzheimer ” . In “Démences” , Edited by: Duyckaerts , C and Pasquier , F . 127 45. France : Doin Groupe Liaisons S.A. .
   Google Scholar
• Folstein , MF , Folstein , SE and McHugh , PR. 1975 . “Mini Mental State.” A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res , 12 : 189 – 198 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Galasko , D. 1998 . Cerebrospinal fluid levels of A beta 42 and tau: Potential markers of Alzheimer’s disease . J Neural Transm Suppl , 53 : 209 – 21 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Gifford , DR and Cummings , JL. 1999 . Evaluating dementia screening tests. Methodologic standards to rate their performance . Neurology , 52 : 224 – 227 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Grober , E , Buschke , H , Crystal , H , Bang , S and Dresner , R. 1988 . Screening for dementia by memory testing . Neurology , 38 : 900 – 903 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hampel , H , Teipel , SJ , Fuchsberger , T , Andreasen , N , Wiltfang , J Otto , M . 2003 . Value of CSF beta-amyloid(1-42) and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment . Mol Psychiatry , [Epub ahead of print]
   Google Scholar
• Hulstaert , F , Blennow , K , Ivanoiu , A , Schoonderwaldt , HC , Riemenschneider , M, De Deyn , PP . 1999 . Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF . Neurology , 52 : 1555 – 62 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Ivanoiu , A , Adam , S Van der Linden , M . 2000 . The episodic memory evaluation in incipient Alzheimer’s disease . J Neurol , 247 ( suppl 3 ) : III/13 Abstract
   Google Scholar
• Ivanoiu , A , Van der Linden , M , Seron , X and Sindic , CJM. 1999 . Contribution of free and cued recall to the early diagnosis of Alzheimer’s disease . J Neurol , 246 ( suppl 1 ) : I/122 Abstract
   Google Scholar
• Lezak , MD. 1995 . “ Evaluation of neuropsychological examination data ” . In Neuropsychological assessment- , 3rd ed. , Edited by: Lezak , MD . 152 – 157 . New York : Oxford University Press .
   Google Scholar
• Knopman , DS , DeKosky , ST , Cummings , JL , Chui , H , Corey-Bloom , J Relkin , N . 2001 . Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology . Neurology , 56 : 1143 – 53 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Maruyama , M , Arai , H , Sugita , M , Tanji , H , Higuchi , M Okamura , N . 2001 . Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer’s disease . Exp Neurol , 172 : 433 – 6 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McKhann , G , Drachman , D Folstein , M . 1984 . Clinical Diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease . Neurology , 34 : 939 – 944 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meiran , N , Stuss , D , Guzman , A , Lafleche , G and Willmer , J. 1996 . Diagnosis of dementia. Methods for interpretation of scores of 5 neuropsychological tests . Arch Neurol , 53 : 1043 – 1054 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Morris , JC , Mohs , RC , Rogers , H , Fillenbaum , G and Heyman , A. 1988 . Cosortium to Establish a Registry for Alzheimer’s Disease (CERAD). Clinical and neuropsychological assessment of Alzheimer’s disease . Psychopharmacol Bull , 24 : 641 – 644 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Motter , R , Vigo-Pelfrey , C , Kholodenko , D , Barbour , R , Johnson-Wood , K Galasko , D . 1995 . Reduction of b-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer’s disease . Ann Neurol , 38 : 643 – 648 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Petersen , RC , Smith , GE , Waring , SC , Ivnik , RJ , Tangalos , EG and Kokmen , E. 1999 . Mild cognitive impairment. Clinical characterization and outcome . Arch Neurol , 56 : 303 – 308 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Riemenschneider , M , Lautenschlager , N , Wagenpfeil , S , Diehl , J , Drzezga , A and Kurz , A. 2002 . Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment . Arch Neurol , 59 : 1729 – 34 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ritchie , K , Artero , S and Touchon , J. 2001 . Classification criteria for mild cognitive impairment: A population-based validation study . Neurology , 56 : 37 – 42 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Rouleau , I , Salmon , DP , Butters , N , Kennedy , C and McGuire , K. 1992 . Quantitative and Qualitative Analyses of Clock Drawings in Alzheimer’s and Huntington Disease . Brain and Cognition , 18 : 70 – 87 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• StatView. Abacus Concepts, Inc. 1992–94
   Google Scholar
• Thompson , SA and Hodges , JR. 2002 . Mild cognitive impairment: a clinically useful but currently ill defined concept? . Neurocase , 8 : 405 – 10 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Vandermeeren , M , Mercken , M , Vanmechelen , E , Six , J , van de Voorde , A , Martin , JJ and Cras , P. 1993 . Detection of tau proteins in normal and Alzheimer’s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay . J Neurochem , 61 : 1828 – 34 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wahlund , LO and Blennow , K. 2003 . Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients . Neurosci Lett , 339 : 99 – 102 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar